 |
|
|
| |
Glecaprevir/pibrentasvir pharmacokinetics
in HCV/HIV patients
co-administered with antiretroviral drugs
|
| |
| |
20th International Workshop on Clinical Pharmacology of HIV, Hepatitis & Other Antiviral Drugs. May 14-16, 2019. Noordwijk, the Netherlands
Reported by Jules Levin
L. Marinaro1, V. Pirriatore1, R. Angilletta1, A. Palazzo1, A. Barco1, C. Alcantarini1, C. Montrucchio2,
M. Ferrara1, MC. Tettoni1, A. De Nicolo3, A. D'Avolio3, A. Calcagno1, G. Di Perri1 and S. Bonora1
1 Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy;
2 Unit of Infectious Diseases, Cardinal Massaia Hospital, Asti, Italy;
3 Interdepartmental Center for Clinical and Experimental Pharmacology (CIFACS), University of Torino, Torino, Italy.
|
| |
|
|
|
|
|
